Gleptosil

Introduction

Company name: Alstoe Ltd

Address: The Industrial Park

Sheriff Hutton

York

YO60 6RZ

Telephone: 01347 878606

Fax: 01347 878333

Email: info@alstoe.co.uk

Website: www.alstoe.co.uk

Presentation

A sterile, dark brown, slightly viscous aqueous colloidal solution containing 200 mg iron as gleptoferron, per mL and 0.5% phenol as preservative.

Uses

For the prevention and treatment of iron deficiency anaemia in piglets.

Dosage and administration

Use only automatic syringe equipment

Swab the septum before use. The product is administered as a single 1 mL (200 mg iron) dose by deep intramuscular injection into the hind limb midway between the stifle joint and the base of the tail. Injections should be administered as follows:

For the prevention of iron deficiency anaemia: not later than the third day of life.

For the treatment of iron deficiency anaemia: at the onset of clinical anaemia, normally within the first three weeks of life.

Contra-indications, warnings, etc

Withdrawal period: zero days

Pharmaceutical precautions

Do not store above 25°. Protect from light. Each bottle is sealed in a transparent sachet; the sachet should not be opened until the bottle is required for use. Avoid the introduction of contamination during use.

Following withdrawal of the first dose, use the product within 28 days.

Keep out of reach of children.

Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.

Legal category

POM-VPS

Packaging Quantities

Carton containing 100 mL collapsible plastic bottle.

Further information

Precautions to be taken by the person administering the product to animals: in case of accidental self-injection or ingestion seek medical advice taking bottle and package leaflet to the physician. Wash hands after use.

There are normally no undesirable side effects associated with the use of the product. Its use does not result in permanent staining of the injected muscle tissue.

Overdosage with the product is unlikely to result in signs of intoxication.

Marketing authorisation number

Vm 14094/4000.

Significant Changes

Significant Changes